Abstract
This letter indicates that there is long-lasting skeletal accumulation of bisphosphonate, and ongoing use appears to be the dominant risk factor for rare fractures.
Cite
CITATION STYLE
APA
Schilcher, J., Koeppen, V., Aspenberg, P., & Michaëlsson, K. (2014). Risk of Atypical Femoral Fracture during and after Bisphosphonate Use. New England Journal of Medicine, 371(10), 974–976. https://doi.org/10.1056/nejmc1403799
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free